The J. Allyn Taylor International Prize in Medicine has been awarded to the University of Pennsylvania’s Dr. Garret FitzGerald who contributed to the development of low-dose aspirin for the prevention of heart disease.
FitzGerald, who chairs the Department of Pharmacology and directs the Institute for Translational Medicine and Therapeutics, was also the first to predict and explain the cardiovascular hazard from nonsteroidal anti-inflammatory drugs.
Dr. Garret FitzGerald
The $10,000-Taylor Prize, awarded annually to recognize leading medical researchers, is supported by Robarts Research Institute and The C. H. Stiller Memorial Foundation.
The name honours the late J. Allyn Taylor, Robarts’ founding chair and a close friend of the Stiller family. The prize was first awarded in 1985.
According to the sponsors “the recipient of this year’s Taylor Prize has made outstanding contributions in the field of cardiovascular research.
FitzGerald will deliver an address at a Celebration of Science dinner on Nov. 4 at the Great Hall at Western. The evening is hosted by Western alumna and CTV News medical specialist Avis Favaro.
The dinner follows the Taylor Prize Symposium the same day, 9 a.m. to 4 p.m. in Auditorium A, London Health Sciences Centre, where FitzGerald will also speak.
For more information, contact Linda Chapman at 519-931-5205 or lchapman@robarts.ca.